Company Filing History:
1 out of 321 
1 out of 5 
1 out of 132 
Years Active: 2020
Title: Emmanuel Martin: Innovator in CTP Detection and Quantification
Introduction
Emmanuel Martin is a notable inventor based in Paris, France. He has made significant contributions to the field of biochemistry, particularly in the detection and quantification of CTP and CTP synthase activity. His innovative methods have potential applications in immunosuppressive and anti-cancer treatments.
Latest Patents
Emmanuel Martin holds a patent for "Methods for detecting or quantifying CTP and CTP synthase activity." This invention relates to a method for detecting or quantifying CTP in a cell sample using cationic ion pairing chromatography coupled to mass spectrometry. It also includes a method for detecting or quantifying CTP synthase activity, which is crucial for screening potential immunosuppressive or anti-cancer compounds.
Career Highlights
Throughout his career, Emmanuel has worked with prominent institutions such as Assistance Publique-Hôpitaux de Paris and Imagine Institute of Genetic Diseases Necker Enfants Malades. His work in these organizations has allowed him to advance his research and contribute to significant scientific discoveries.
Collaborations
Emmanuel has collaborated with several professionals in his field, including Sylvia Sanquer and Anne-Claire Boschat. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Emmanuel Martin's innovative work in the detection and quantification of CTP and CTP synthase activity showcases his dedication to advancing biochemistry. His contributions have the potential to influence the development of new therapeutic strategies.